Glyphic Biotechnologies is a startup based in the United States, 4 tracked investors.
Glyphic Biotechnologies is a startup founded in 2021 based in the United States. Brouky records 4 investors associated with the company.
Glyphic Biotechnologies develops a de novo high-throughput proteome sequencing technology called Protein Sequencing by Expansion (ProSE™), enabling accurate single molecule discrimination of all 20 amino acids and post-translational modifications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.